Dr. Ala Abudayyeh is the director of Clinical Research, Division of Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. She completed her PhD studies in Internal Medicine at the University of Texas-Houston Medical School. She is a member of the Executive Committee, Toxicity Executive Committee, and co-chair of CPI-induced Renal toxicity, DoIM TOXICITIES RESEARCH SUB GROUP. Her scientific interests are focused on the study of onco-nephrology, transplant oncology, immunotherapy, immunotherapy toxicity, and renal transplant.